Hofseth BioCare ASA (OSL: HBC)
Norway
· Delayed Price · Currency is NOK 1.600
+0.065 (4.23%)
Dec 23, 2024, 4:25 PM CET
Hofseth BioCare ASA Market Cap
Hofseth BioCare ASA has a market cap or net worth of 657.73 million as of December 27, 2024. Its market cap has decreased by -37.65% in one year.
Market Cap
657.73M
Enterprise Value
829.25M
Revenue
248.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
Market Cap Chart
Since December 2, 2011, Hofseth BioCare ASA's market cap has increased from 285.82M to 657.73M, an increase of 130.12%. That is a compound annual growth rate of 6.59%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nordhealth AS | 3.15B |
| Medistim ASA | 2.75B |
| Photocure ASA | 1.73B |
| Carasent ASA | 1.53B |
| Nykode Therapeutics AS | 986.17M |
| ArcticZymes Technologies ASA | 684.36M |
| Thor Medical ASA | 624.73M |
| Gentian Diagnostics ASA | 619.98M |